Friday, November 13, 2026
Nexalin Technology Posts Third-Quarter 2026 Results
The company shared its numbers for the three months ended in 2026's third quarter. The release covers its performance for that stretch.
Wednesday, October 28, 2026
Nexalin Technology Reports Fourth Peer-Reviewed Publication on Alzheimer's Disease
Nexalin Technology said it has added a fourth peer-reviewed publication related to Alzheimer's disease. The company did not give further details in the announcement.
Tuesday, October 27, 2026
Nexalin Technology Says Fourth Peer-Reviewed Paper Covers Alzheimer's Clinical Findings
Nexalin Technology announced that another peer-reviewed article has been published, this one reporting clinical study results for its 15 mA DIFS treatment in Alzheimer's disease. It marks the fourth such reviewed publication for the company.
Thursday, October 8, 2026
Nexalin Technology back in line with Nasdaq bid price rule
Nexalin Technology said it has regained compliance with Nasdaq's minimum bid price listing standard. The company still needs to satisfy a $2.5 million equity threshold by January 4, 2027.
Friday, October 2, 2026
Dow Rises More Than 300 Points as September Payrolls Grow by 29,000
The Dow gained over 300 points after the US economy added 29,000 jobs in September. The payrolls figure shows hiring continued during the month.
Thursday, October 1, 2026
Nasdaq Adds 100 Points as September Factory Gauge Falls
The tech-heavy index climbed 100 points. A monthly survey of U.S. factory activity weakened in September.
Nexalin Technology stock halted on circuit breaker, up 92.76%
Trading in Nexalin Technology was paused by a circuit breaker as the share price climbed. The stock was up 92.76% at the time of the halt.
Thursday, September 3, 2026
Form S-1 registers new shares with the SEC, often before an offering.
Nexalin analysis finds ADAS-Cog gains in 10 of 20 patients
Nexalin reported that a post hoc review of its Alzheimer's device study showed half of the 20 evaluable participants on active treatment gained at least 4 points on ADAS-Cog. The results will shape a planned U.S. pilot study.
Thursday, August 27, 2026
Nexalin Technology sets 1-for-30 reverse share consolidation
Nexalin Technology disclosed a plan to combine every 30 of its shares into one. Its stock moved lower after the news came out.
Nexalin Technology approves share consolidation taking effect August 28
Nexalin Technology will reduce its share count by combining each group of thirty shares into a single share, effective August 28.
Frequently asked questions
What is the latest news on NXL?
Nov 13, 2026: Nexalin Technology Posts Third-Quarter 2026 Results (Fiscal.ai) · Oct 28, 2026: Nexalin Technology Reports Fourth Peer-Reviewed Publication on Alzheimer's Disease (Fiscal.ai) · Oct 27, 2026: Nexalin Technology Says Fourth Peer-Reviewed Paper Covers Alzheimer's Clinical Findings (Benzinga)
What has NXL filed with the SEC recently?
Sep 3, 2026: Nexalin Technology, Inc. filed a registration statement for new shares (Form S-1)
Get NXL news as it happens
Every headline, SEC filing and analyst action for NXL on your live chart, with important news marked and alerts when it matters.
Try SEPT Free